课题基金 / 基金详情

Induction of activated leukocyte-selective apoptosis by the fusion protein IL10-GCSF

Induction of activated leukocyte-selective apoptosis by the fusion protein IL10-GCSF
融合蛋白 IL10-GCSF 诱导激活的白细胞选择性凋亡
批准号:
21591651
负责人:
HAYAMIZU Keisuke
金额:
$2.83万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

HAYAMIZU Keisuke的其他基金

相似基金

相关文献

中文摘要
翻译
I基因合成了白介素10(IL10)和粒细胞集落刺激因子(GCSF)的融合蛋白,白介素10促进激活的中性粒细胞凋亡,粒细胞集落刺激因子与中性粒细胞高度结合,在血液中保留较长的半衰期。用RT-PCR法将人GCSFc DNA和人IL10c DNA亚克隆到pSP73载体上,作为感受态细胞在DH5α中扩增。我们设计了野生型IL10、野生型IL10(IL10M)、野生型GCSF与IL10M融合蛋白以及拮抗型GCSF与IL10M融合蛋白,并利用无细胞蛋白质合成系统进行翻译。用抗IL10和GCSF抗体的夹心ELISA法检测到合成的融合蛋白上的这两个表位。使用抗IL10抗体的流式细胞术显示融合蛋白与人白细胞结合。野生型IL-10和IL-10M能强烈抑制脂多糖刺激的白细胞产生炎性细胞因子IL-12和肿瘤坏死因子α,其抑制程度与IL-10相当。这些结果有力地表明,合成的IL10M和GCSF融合蛋白有望成为新型抗炎药物的候选药物。
英文摘要
I genetically synthesized the fusion proteins of interleukin 10(IL10) which facilitates apoptosis of the activated neutrophils and granulocyte colony-stimulating factor(GCSF) which highly binds neutrophils and is retained with longer half-lives in blood. cDNA of a human GCSF clone and that of human IL10 prepared from a volunteer by RT-PCR were subcloned into the plasmid pSP73 and propagated in DH5α as competent cells. The cDNA of antagonistic GCSF was synthesized by mutation at the site III, and that of IL10 was monomerized by elongation of the hinge between the helix D and E. I designed cDNAs of such wild-type IL10, monomerized IL10(IL10M), a fusion protein of wild-type GCSF and IL10M, and a fusion protein of antagonistic GCSF and IL10M, then translated them using a cell-free protein synthesis system. Sandwich ELISA with antibodies to IL10 and GCSF detected both epitopes on those synthesized fusion proteins. Flow cytometry using an anti-IL10 antibody demonstrated binding of the fusion proteins to human leukocytes. The wild-type IL10 and IL10M strongly suppressed production of inflammatory cytokines as IL12 and TNFα by LPS-stimulated leukocytes, and the degree of IL12 suppression by the fusion proteins was comparable to the IL10s. These results strongly suggest that the synthesized fusion proteins of IL10M and GCSF are promising candidates for new anti-inflammatory drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Relationship between the cAMP levels in leukocytes and the cytokine balance in patients surviving gram negative bacterial pneumonia.
革兰氏阴性细菌性肺炎患者白细胞 cAMP 水平与细胞因子平衡之间的关系。
DOI: --
发表时间: 2011
期刊: Journal of Biochemistry and Nutrition
影响因子: --
作者: [Matsumoto T, Hayamizu K, Marubayashi S, et al.]
通讯作者: et al.
DOI: --
发表时间: 2011
期刊: Journal of Biochemistry and Nutrition
影响因子: --
作者: [Matsumoto T, Hayamizu K, Marubayashi S, et al.]
通讯作者: et al.
Preventive effect of G-CSF on acute lung injury via alveolar macrophase regulation
G-CSF通过肺泡巨相调节对急性肺损伤的预防作用
DOI: --
发表时间: 2012
期刊: Journal of Surgical Research
影响因子: 2.2
作者: [Yamaguchi T, Miyata Y, Hayamizu K, et al]
通讯作者: et al
An influence of granulocyte colony-stimulating factor upon pathogenesis of inflammatory bowel disease
  • 批准号:
    16591320
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.11万
  • 财政年份:
    2004
  • 负责人:
    HAYAMIZU Keisuke
  • 依托单位:
国内基金
海外基金
融合蛋白纳米系统介导的肿瘤微环境“基质解构—免疫激活”双靶干预策略对免疫检查点阻断疗法增敏效应的研究
  • 批准号:
    22578163
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2025
  • 负责人:
    高敏
  • 依托单位:
对虾精卵融合蛋白的鉴定及其在对虾CRISPR/Cas9基因编辑系统中的应用研究
  • 批准号:
    32503172
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    宋柳
  • 依托单位:
重组人II型肿瘤坏死因子受体-抗体融合蛋白注射液在炎症性关节炎真实世界人群中的应用示范
内源性膜融合蛋白功能化的免疫隐形脂质纳米粒平台用于核酸药物递送的研究